In the course of a DNA methylation screening in sarcoma cells using a methylated CpG island amplification coupled with representational difference analysis (MCA-RDA) approach, we identified the ECRG4 gene at 2q12.2 as a gene showing aberrant promoter methylation in tumor but not in normal cells. This evidence concerns the gene ECRG4 and neoplasm.